Related Experiment Video
Updated: Oct 4, 2025

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
Published on: July 6, 2021
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity
Preetish Kadur Lakshminarasimha Murthy1, Rui Xi2, Diana Arguijo3
1Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USA; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Oncogenic Kras induces a hyper-proliferative state that permits cells to progress to neoplasms in diverse epithelial tissues. Depending on the cell of origin, this also involves lineage transformation. Although a multitude of downstream factors have been implicated in these processes, the precise chronology of molecular events controlling them remains elusive. Using mouse models, primary human tissues, and cell lines, we show that, in Kras-mutant alveolar type II cells (AEC2), FOSL1-based AP-1 factor guides the mSWI/SNF complex to increase chromatin accessibility at genomic loci controlling the expression of genes necessary for neoplastic transformation. We identified two orthogonal processes in Kras-mutant distal airway club cells. The first promoted their transdifferentiation into an AEC2-like state through NKX2.1, and the second controlled oncogenic transformation through the AP-1 complex. Our results suggest that neoplasms retain an epigenetic memory of their cell of origin through cell-type-specific transcription factors. Our analysis showed that a cross-tissue-conserved AP-1-dependent chromatin remodeling program regulates carcinogenesis.
Insights
Oncogenic Kras mutations drive cancer by altering cell proliferation and identity. A FOSL1-based AP-1 factor controls chromatin remodeling, essential for neoplastic transformation in Kras-mutant cells.
Area of Science:
- Molecular biology
- Cancer research
- Epigenetics
Background:
- Oncogenic Kras mutations promote uncontrolled cell growth and tissue neoplasms.
- Kras-driven carcinogenesis involves lineage transformation, but the molecular timeline is unclear.
Purpose of the Study:
- To elucidate the molecular events and epigenetic mechanisms driving Kras-induced neoplastic transformation.
- To investigate the role of transcription factors and chromatin remodeling in Kras-mutant cells.
Main Methods:
- Utilized mouse models, primary human tissues, and cell lines.
- Analyzed Kras-mutant alveolar type II cells (AEC2) and distal airway club cells.
- Investigated the function of FOSL1-based AP-1 and the mSWI/SNF complex in chromatin accessibility.
Main Results:
- In Kras-mutant AEC2, FOSL1-AP-1 directs mSWI/SNF to remodel chromatin, enabling expression of oncogenic transformation genes.
- Kras-mutant club cells undergo transdifferentiation via NKX2.1 and oncogenic transformation via AP-1.
- A conserved AP-1-dependent chromatin remodeling program regulates carcinogenesis across tissues.
Conclusions:
- Neoplasms retain epigenetic memory of their cell of origin.
- Cell-type-specific transcription factors and AP-1-mediated chromatin remodeling are critical in Kras-driven cancer.
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle

